Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024 [Yahoo! Finance]
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024 [Yahoo! Finance]
Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.